Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...